Loading
Terumo Blood and Cell Technologies
Maker of the Spectra Optia apheresis system used to collect cells for most CAR-T products, and of the Quantum cell-expansion system.
Overview
Terumo Blood and Cell Technologies, based in Lakewood, Colorado, and a subsidiary of Japan's Terumo, makes the Spectra Optia apheresis system used to collect cells for most CAR-T products, and the Quantum cell expansion system. Its portfolio covers apheresis, blood component and cell therapy manufacturing devices. OnCo links it to apheresis and starting-material collection and to closed automated cell therapy manufacturing. Whether apheresis capacity, rather than manufacturing, becomes the limiting step as CAR-T demand grows is the open question its position highlights. The apheresis technology page carries the wider picture.
Connected
3Similar pages
- CompanyCellares
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- CompanyMiltenyi Biotec
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- CompanyFresenius Kabi
Shares Apheresis and starting-material collection and the tag supporting.
- CompanyCytiva (Danaher)
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- TechnologyCell-therapy release and potency testing
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- CompanyLonza
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- TechnologyCryopreservation and cell-therapy cold chain
Shares Apheresis and starting-material collection and the tag supporting.
- TechnologyPoint-of-care and decentralised cell manufacturing
Shares Closed automated cell-therapy manufacturing and the tag supporting.
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
terumobct.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/